Mechanism of action
Mannitol (Mannitum / Mannitolum) differs fundamentally from other diuretics (e.g., furosemide, acetazolamide, or spironolactone). Its action is based exclusively on physicochemical properties — it does not interact with enzymes or epithelial cell receptors.
Following intravenous administration, the drug is filtered through the renal glomerular capillary endothelium and enters the lumen of the nephron tubules. Mannitol does not undergo tubular reabsorption and acts throughout the entire tubular apparatus. Its key sites of action are zones of free water reabsorption via aquaporins:
- Proximal tubules;
- Descending limb of the loop of Henle;
- Collecting ducts.
Present in the lumen, the drug creates and maintains high osmotic pressure, preventing the passive reabsorption of water.
Pharmacological effects
Two main directions of the drug's action are distinguished:
- Diuretic effect. Due to high osmotic activity, mannitol retains water within the tubular lumen. This leads to a significant increase in the volume of secondary urine. Sodium ion reabsorption is secondarily (and very slightly) decreased.
- Dehydrating effect. Present in the blood, the drug increases plasma osmotic pressure. Because mannitol poorly penetrates biological membranes (tissue barriers), it creates a pressure gradient that drives fluid movement from tissues into the vascular bed. This is especially effective for tissues protected by blood-tissue barriers (brain tissue, eyeball).
Interesting fact: the osmotic effect of mannitol is utilized to artificially disrupt the permeability of the blood-brain barrier (BBB). Increasing osmotic pressure disrupts the structure of capillary endothelial tight junctions, enhancing paracellular transport. This allows the delivery of chemotherapeutic agents for malignant brain tumors.
Pharmacokinetics
The drug does not undergo hepatic biotransformation (metabolism) in the body. It is excreted unchanged via glomerular filtration. Elimination is very rapid — the bulk of it is excreted within 30–60 minutes after intravenous administration.
Indications for use
Due to its properties, mannitol is used in emergency medicine and intensive care:
- Brain edema: utilizes the powerful dehydrating capacity of the drug.
- Acute glaucoma attack: for rapid reduction of intraocular pressure.
- Chemical poisonings: as part of forced diuresis for accelerated toxin elimination (often combined with 1–2 L of 0.9% NaCl solution or loop diuretics).
- Oliguria: in conditions associated with hemodynamic disturbances (trauma, burns, blood loss) to maintain glomerular filtration.
Side effects
The use of mannitol may be accompanied by the following adverse reactions:
- General symptoms: weakness, dry mouth.
- Cardiovascular system: tachycardia.
- Central nervous system: risk of seizures.
Dosage form and rules of administration
The drug is administered exclusively intravenously (bolus or infusion).
- Dosage: calculated as 0.5–1.5 g/kg of body weight. The maximum daily dose (MDD) is 140–180 g.
- Formulations:
- 15% solution in 200, 400, and 500 ml ampoules.
- Powder in 30.0 g vials. The solution from powder is prepared ex tempore (immediately before use) by dissolving it in 200 ml of water for injection or in a 5% glucose solution.
Briefly: answers to topical questions
What side effects does mannitol cause?
Mannitol (Mannitolum) causes certain adverse effects across various body systems. The main undesirable reactions during its clinical use include:
- General symptoms — onset of weakness, dry mouth;
- Cardiovascular system — tachycardia;
- Central nervous system — risk of seizures.
What are the contraindications to the use of mannitol?
Contraindications to the use of mannitol (Mannitolum) depend on the clinical situation and the dosage form. They include:
- Hypernatremia — sodium levels at or above the upper limit of normal due to the risk of brain cell swelling;
- Acute renal failure — serves as a limitation for administration in cerebral edema and swelling;
- Pediatric age — under 6 years (contraindicated for inhalation powder).
How does mannitol affect electrolyte excretion (sodium, potassium, chloride)?
Mannitol (Mannitolum) causes a secondary and negligible decrease in the reabsorption of sodium ions ($Na^+$). This occurs against the background of water retention in the renal tubular lumen due to the drug's high osmotic activity and a significant increase in secondary urine volume. Data on the direct effect of mannitol on potassium and chloride ion excretion are absent in the provided materials.
Mannitol acts as an OSMOTIC SPONGE: it does not cross barriers on its own, is not absorbed, but pulls water from tissues (brain, eye) and retains it in the renal tubules.
Class and exam questions
Why is mannitol effective in brain edema?
It does not cross an intact BBB. By increasing plasma osmolarity, the drug creates a pressure gradient that moves excess fluid from brain tissues into the vascular bed.
In which nephron segments does mannitol act?
Throughout all parts of the tubules, but key sites are zones of free water reabsorption via aquaporins: proximal tubules, descending limb of the loop of Henle, and collecting ducts.
Does mannitol bind to receptors in the kidneys?
No. This is the only diuretic whose mechanism is based exclusively on physicochemical properties (increasing osmotic pressure) rather than interaction with enzymes or receptors.
Does mannitol undergo metabolism?
No, it is not metabolized in the body and is rapidly excreted unchanged via glomerular filtration (within 30–60 minutes).
What else to study on this topic
- Comparative profile of osmotic and loop diuretics
- Methodology of forced diuresis in acute poisonings
- Blood-tissue barriers: BBB and blood-ocular barrier
- Paracellular transport and the structure of tight junctions
- Oliguria in shock states: pathophysiology and the role of diuretics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Mannitol" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.